- August 30, 2013Technology: Will the Digital Millennium Copyright Act Takedown 3D Printing?
- August 19, 2013Consumer Alert: Lariam Antimalarial Drug and Permanent Neuropsychological Side Effects
- August 16, 2013Technology: Balancing Data Analytics, Data Privacy and Ediscovery
- August 16, 2013No Heightened Pleading Standard for Antitrust Plaintiffs
- August 16, 2013FTC Decision May Provide Comfort to Competitor-Information Exchanges
- August 2, 2013Technology: Facebook, Food and the FDA
- August 13, 2013Considerations Relating to Named Storm Provisions
- August 7, 2013Honesty Still Matters, as Told by Espedito v. Nat'l Fire
- August 2013Moving Forward with Loss-of-Chance Claims
- August 5, 2013Operating Room Fires
- July 24, 2013Use Arbitration to Protect Non-Competes
- July 17, 2013Hospital “Never Events”: Retained Surgical Instruments and the Legal Consequences
- Aventis Pharma., Inc. v. Amino Chemicals Ltd.
- Alcon Research, Ltd. v. Apotex, Inc.
- Summer 2013New ANDA Cases
- Takeda Pharm. Co., Ltd. v. TWI Pharm., Inc.
- FTC v. Actavis, Inc.
- Purdue Pharma L.P. v. Varam, Inc.
- Novo Nordisk A/S v. Caraco Pharma. Labs., Ltd.
- Generic Launches
- Shire Development LLC v. Watson Pharma., Inc.
- Allergan, Inc. v. Sandoz, Inc.
- Dey, L.P. v. Sunovion Pharma., Inc.
- AstraZeneca LP v. Breath Ltd.
- Allergan, Inc. v. Apotex, Inc.
- Summer 2013ANDA Approvals
- July 15, 2013Now You See It . . . Vacating Precedent
- Takeda Pharma. Co., Ltd. v. Zydus Pharma. USA Inc.
- Bayer Healthcare Pharma., Inc. v. Watson Pharma., Inc.
- Braintree Labs., Inc. v. Novel Labs., Inc.
- Summer 2013ANDA Litigation Settlements
- July 10, 2013Structural Complexity as a Cover for Fraud? Analyzing Losses from Exotic Structured Investment Products
- July 10, 2013Meet Our In House Economic Consultants
- June 20, 2013Benefits, Hazards of Joint Advocacy
- June 18, 2013Modern Surgical Technology and the Danger of Operating Room Fire
- June 10, 2013FTC Decision May Reassure Info‐Exchange Participants
- June 3, 2013Using Regression Models to Isolate the Value of a Patented Feature
- May 28, 2013SEC Investigations 101: 20 Frequently Asked Questions
- May 16, 20135 Overlooked Reasons To Be Class Rep In An Antitrust Suit
- May 17, 2013Staying Alive: Appeals and Stays
- May 8, 2013A Trial Lawyers Guide to the New FTC Green Labeling Guidelines
- May 3, 2013Enforcing International Arbitral Awards in U.S. Courts
- May 2013Different Rules, Different Results: Patent Litigation After In re Baxter
- April 24, 2013Why the Auto-Owners v. Second Chance Ruling Is Unique
- April 23, 2013IP: India, Generics and the Impact of Novartis’ Failed Gleevec Claims
- Sunovion Pharma. Inc. v. Teva Pharma. USA, Inc.
- Pfizer Inc. v. Watson Pharma., Inc.
- Allergan, Inc. v. Barr Lab., Inc.
- Senju Pharma. Co. Ltd. v. Apotex, Inc.
- In re Fenofibrate Patent Litig.
